M.D.C. Holdings, Inc. (NYSE:MDC) Expected to Announce Earnings of $2.43 Per Share

Wall Street analysts expect that M.D.C. Holdings, Inc. (NYSE:MDCGet Rating) will report earnings of $2.43 per share for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for M.D.C.’s earnings, with estimates ranging from $2.32 to $2.53. M.D.C. posted earnings of $2.11 per share in the same quarter last year, which would suggest a positive year-over-year growth rate of 15.2%. The business is expected to report its next quarterly earnings report on Monday, January 1st.

On average, analysts expect that M.D.C. will report full year earnings of $10.65 per share for the current fiscal year, with EPS estimates ranging from $10.12 to $11.53. For the next financial year, analysts forecast that the business will report earnings of $10.79 per share, with EPS estimates ranging from $9.21 to $11.75. Zacks Investment Research’s EPS averages are an average based on a survey of analysts that follow M.D.C..

M.D.C. (NYSE:MDCGet Rating) last released its quarterly earnings data on Thursday, April 28th. The construction company reported $2.02 earnings per share for the quarter, beating the consensus estimate of $1.91 by $0.11. The company had revenue of $1.24 billion during the quarter, compared to analyst estimates of $1.22 billion. M.D.C. had a net margin of 11.24% and a return on equity of 24.22%. M.D.C.’s revenue for the quarter was up 19.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.51 EPS.

Several analysts recently issued reports on MDC shares. JPMorgan Chase & Co. reduced their price target on shares of M.D.C. from $49.00 to $39.00 and set a “neutral” rating for the company in a research report on Wednesday, April 13th. StockNews.com started coverage on shares of M.D.C. in a research report on Thursday, March 31st. They issued a “hold” rating for the company. Wedbush reissued a “neutral” rating on shares of M.D.C. in a research report on Tuesday, February 1st. Finally, Zacks Investment Research raised shares of M.D.C. from a “hold” rating to a “buy” rating and set a $51.00 price target for the company in a research report on Friday, February 4th. Three equities research analysts have rated the stock with a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $55.67.

In other M.D.C. news, Director David E. Blackford sold 3,000 shares of M.D.C. stock in a transaction on Tuesday, May 3rd. The shares were sold at an average price of $38.12, for a total transaction of $114,360.00. Following the transaction, the director now directly owns 19,748 shares of the company’s stock, valued at approximately $752,793.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 24.20% of the stock is owned by insiders.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Louisiana State Employees Retirement System raised its stake in M.D.C. by 0.7% in the 4th quarter. Louisiana State Employees Retirement System now owns 27,400 shares of the construction company’s stock valued at $1,530,000 after acquiring an additional 200 shares during the period. O Shares Investment Advisers LLC raised its stake in shares of M.D.C. by 2.3% during the fourth quarter. O Shares Investment Advisers LLC now owns 9,708 shares of the construction company’s stock worth $542,000 after acquiring an additional 220 shares in the last quarter. CIBC Asset Management Inc raised its stake in shares of M.D.C. by 5.3% during the third quarter. CIBC Asset Management Inc now owns 4,434 shares of the construction company’s stock worth $207,000 after acquiring an additional 224 shares in the last quarter. Voya Investment Management LLC raised its stake in shares of M.D.C. by 0.6% during the third quarter. Voya Investment Management LLC now owns 39,132 shares of the construction company’s stock worth $1,828,000 after acquiring an additional 232 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in shares of M.D.C. by 0.6% in the third quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 42,836 shares of the construction company’s stock worth $2,001,000 after buying an additional 237 shares during the period. Institutional investors own 83.86% of the company’s stock.

Shares of NYSE:MDC traded up $0.38 during mid-day trading on Tuesday, hitting $37.22. The company had a trading volume of 2,104 shares, compared to its average volume of 687,200. The firm has a fifty day moving average price of $38.62 and a 200 day moving average price of $45.82. The company has a market capitalization of $2.65 billion, a PE ratio of 4.47 and a beta of 1.34. The company has a debt-to-equity ratio of 0.61, a current ratio of 7.20 and a quick ratio of 1.49. M.D.C. has a one year low of $34.56 and a one year high of $58.92.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 25th. Shareholders of record on Wednesday, May 11th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 5.37%. The ex-dividend date is Tuesday, May 10th. M.D.C.’s dividend payout ratio is 24.01%.

About M.D.C. (Get Rating)

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.

Featured Stories

Get a free copy of the Zacks research report on M.D.C. (MDC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for M.D.C. (NYSE:MDC)

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.